top of page

Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A

Apr 9, 2024

She describes working with Steven Paul again, the Glyph technology that is the backbone of Seaport's platform, and initial programs in the neuropsychiatry space.

Recent Posts

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space

Stoke Therapeutics' CEO Ed Kaye discusses today's partnership news with Biogen on Zorevunersen for the treatment of Dravet syndrome

Stoke Therapeutics' CEO Ed Kaye discusses today's partnership news with Biogen on Zorevunersen for the treatment of Dravet syndrome

The CEO of Solid Biosciences discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy

The CEO of Solid Biosciences discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page